For AD, the levels of multiple mediators, including cytokines and chemokines such as IL-1β, are elevated in the cerebrospinal fluid (CSF) and post-mortem brain tissues of patients with a history of neuroinflammatory conditions [29, 30]. The gene discussed is IL1B; the disease is Alzheimer disease.